Daniel F Alonso Selected Research

von Willebrand Factor

10/2015	Cirrhosis, von Willebrand Factor (vWF) and the Low Incidence of Metastatic Malignancy in Injured Liver.
1/2015	A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients.
1/2013	Implication of von Willebrand factor as a regulator of tumor cell metastasis: potential perioperative use of desmopressin and novel peptide analogs.
12/2012	Re: Effect of ADAM28 on carcinoma cell metastasis by cleavage of von Willebrand factor.
11/2006	Desmopressin reduces melanoma lung metastasis in transgenic mice overexpressing tissue inhibitor of metalloproteinases-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel F Alonso Research Topics

Disease

73	Neoplasms (Cancer) 12/2023 - 01/2002
25	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2002
23	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2002
17	Carcinoma (Carcinomatosis) 08/2023 - 01/2002
15	Melanoma (Melanoma, Malignant) 07/2012 - 03/2002
9	Lung Neoplasms (Lung Cancer) 01/2018 - 12/2003
7	Hemorrhage 10/2020 - 09/2002
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2018 - 12/2007
6	Experimental Melanoma 07/2012 - 12/2002
5	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 01/2017
4	COVID-19 01/2022 - 09/2020
4	Retinoblastoma (Glioblastoma, Retinal) 12/2016 - 03/2010
4	Neuroblastoma 01/2016 - 03/2010
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018 - 02/2007
2	Osteosarcoma (Osteogenic Sarcoma) 10/2023 - 01/2022
2	Glioma (Gliomas) 09/2022 - 01/2014
2	Colonic Neoplasms (Colon Cancer) 07/2020 - 12/2010
2	Disease Progression 01/2020 - 05/2008
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 01/2017
2	Lewis Lung Carcinoma 01/2017 - 01/2012
2	Circulating Neoplastic Cells 01/2016 - 01/2015
2	Carcinogenesis 01/2014 - 01/2012
2	Residual Neoplasm 09/2008 - 12/2006
2	Lymphatic Metastasis 11/2006 - 09/2002
1	Necrosis 01/2022
1	Rectal Neoplasms (Rectal Cancer) 10/2020
1	Body Weight (Weight, Body) 07/2020

Drug/Important Bio-Agent (IBA)

26	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 12/2023 - 09/2002
21	Peptides (Polypeptides)IBA 12/2023 - 01/2008
17	Vasopressins (Vasopressin)IBA 12/2023 - 09/2002
17	GangliosidesIBA 08/2018 - 03/2002
15	VaccinesIBA 12/2015 - 03/2002
12	CIGB-300IBA 01/2020 - 10/2004
8	Monoclonal AntibodiesIBA 08/2023 - 03/2002
8	EnzymesIBA 09/2018 - 01/2002
7	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 01/2019 - 11/2006
7	AntigensIBA 08/2018 - 03/2002
7	racotumomabIBA 08/2018 - 01/2010
7	Messenger RNA (mRNA)IBA 12/2016 - 05/2008
5	Arginine Vasopressin (Argipressin)IBA 12/2023 - 10/2008
5	Hemostatics (Antihemorrhagics)IBA 10/2020 - 09/2002
5	Cytostatic AgentsIBA 01/2020 - 01/2009
5	Casein Kinase II (Casein Kinase 2)IBA 01/2017 - 10/2004
5	von Willebrand FactorIBA 10/2015 - 11/2006
4	Antineoplastic Agents (Antineoplastics)IBA 10/2023 - 10/2010
4	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2016 - 01/2002
4	Proteins (Proteins, Gene)FDA Link 10/2011 - 01/2003
4	G(M3) GangliosideIBA 01/2011 - 12/2002
3	Antiviral Agents (Antivirals)IBA 09/2021 - 09/2020
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2020 - 10/2004
3	AntibodiesIBA 08/2018 - 02/2007
3	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 01/2005
3	Cancer VaccinesIBA 07/2012 - 03/2002
3	Sulfoglycosphingolipids (Sulfatides)IBA 01/2012 - 02/2007
3	Cyclic PeptidesIBA 07/2011 - 10/2004
2	Cisplatin (Platino)FDA LinkGeneric 10/2023 - 01/2022
2	Ivermectin (Mectizan)FDA Link 09/2021 - 07/2021
2	Complement System Proteins (Complement)IBA 04/2019 - 01/2016
2	Transcription Factors (Transcription Factor)IBA 12/2016 - 07/2015
2	Carmustine (FIVB)FDA Link 01/2016 - 09/2008
2	valyl(4)-glutaminyl(5)- desmopressinIBA 01/2016 - 12/2011
2	aluminum sulfate (alum)IBA 01/2016 - 01/2012
2	Monomeric GTP-Binding ProteinsIBA 01/2014 - 01/2014
2	(N- acetylneuraminyl)- galactosylglucosylceramide N-acetylgalactosaminyltransferaseIBA 09/2013 - 03/2010
2	GD2 gangliosideIBA 09/2013 - 03/2010
2	Anti-Idiotypic AntibodiesIBA 01/2013 - 12/2003
2	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2012 - 01/2012
2	Neoplasm Antigens (Tumor Antigens)IBA 07/2012 - 01/2012
2	CMPacetylneuraminate monooxygenase (CMP-N-acetylneuraminate monooxygenase)IBA 07/2012 - 12/2009
2	NucleophosminIBA 04/2012 - 10/2011
2	Aluminum Hydroxide (Algeldrate)FDA Link 01/2012 - 01/2012
2	GlycolipidsIBA 01/2012 - 03/2002
2	Cell-Penetrating PeptidesIBA 07/2011 - 01/2008
2	Formaldehyde (Formol)FDA Link 01/2011 - 01/2010
2	ParaffinIBA 01/2011 - 01/2010
2	N-glycolylneuraminyllactosylceramide (HD3)IBA 01/2011 - 01/2010
2	Tissue Inhibitor of Metalloproteinase-1IBA 11/2006 - 01/2003
2	Peptide Hydrolases (Proteases)FDA Link 10/2006 - 01/2002
2	Metalloproteases (Metalloproteinases)IBA 10/2006 - 01/2005
2	beta-chimaerinIBA 01/2005 - 05/2003
1	Fluorouracil (Carac)FDA LinkGeneric 12/2023
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 12/2023
1	deoxyuridine triphosphateIBA 12/2023
1	Cyclin-Dependent Kinase Inhibitor p21IBA 12/2023
1	Biosimilar PharmaceuticalsIBA 08/2023
1	Bevacizumab (Avastin)FDA Link 08/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2023
1	Small Interfering RNA (siRNA)IBA 01/2022
1	Propranolol (Inderal)FDA LinkGeneric 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	Free RadicalsIBA 07/2020

Therapy/Procedure

18	Therapeutics 12/2023 - 03/2002
10	Drug Therapy (Chemotherapy) 12/2023 - 09/2008
9	Immunotherapy 01/2022 - 11/2004
4	Intravenous Administration 12/2023 - 09/2008
2	Radiotherapy 10/2020 - 01/2016
2	Blood Transfusion (Blood Transfusions) 09/2018 - 11/2017
2	Operative Surgical Procedures 01/2015 - 12/2010
1	Oral Administration 07/2020
1	Castration 01/2019